Isaac Cheng

Insider Reports History

Entity
Individual
Location
C/O Atea Pharmaceuticals, Inc., 125 Summer Street, Boston, MA
Signature
/s/ Joshua B. Cohen, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Isaac Cheng:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Amylyx Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 19K Jun 9, 2022 Direct

Insider Reports Filed by Isaac Cheng

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AMLX Amylyx Pharmaceuticals, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
AMLX Amylyx Pharmaceuticals, Inc. Jan 6, 2022 10 $125K 4 Jan 10, 2022 Director
AMLX Amylyx Pharmaceuticals, Inc. Jan 6, 2022 0 $0 3 Jan 6, 2022 Director